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Abstract  Brain  tumors  are  the  second  leading  cause  of  cancer  in  children.  Primary  tumors
predominate  and  are  of  very  varied  histological  types.  Their  prognosis  and  treatment  depend
on the  histological  type  and  grade.  The  diagnostic  approach  to  these  includes  analysis  of  the
site of  the  lesion  and  appearances  on  computed  tomography  and  MR,  and  taking  account  of
the age  and  clinical  features  of  the  child.  CT  is  used  to  diagnose  the  tumor  in  an  emergency
situation. Conventional  MR  provides  a  morphological  approach  and  allows  a  staging  assessment
to be  carried  out  before  surgery.  Advanced  MR  techniques  (diffusion-weighted  and  perfusion
imaging,  MR  spectroscopy)  provide  further  information  for  the  differential  diagnosis,  presump-
tive diagnosis  of  type  and  grade  and  to  guide  biopsy  towards  the  most  malignant  areas  in  the
lesion.
© 2014  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Brain  tumors  are  the  commonest  tumors  (20—22%)  in  children  after  leukemias  (30%),
although  they  are  still  the  leading  cause  of  cancer  deaths  [1]  and  have  a  number  of  speciﬁc
features  compared  to  adults.
Clinical signs
The  clinical  signs  are  multiple  and  non-speciﬁc  and  depend  on  the  site  of  the  tumor  and  age
of  the  child.  These  include  signs  of  raised  intracranial  pressure  (RICP)  and  various  neurolog-
ical  signs  (epilepsy,  visual  and  endocrine  disturbances,  ataxia,  and  cranial  nerve  palsies).
Signs  are  more  misleading  in  young  children  (macrocephaly,  bulging  of  the  fontanelles,
feeding  difﬁculties,  failure  to  acquire  new  skills,  hypotonia  and  irritability).
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account  for  over  80%  of  childhood  tumors  [4].  Glioblastoma66  
ype
nlike  adults,  metastases  are  very  rare  in  children.  Brain
umors  are  almost  invariably  primary  and  extra-axial  tumors
re  extremely  rare  and  are  predisposed  to  by  genetic
hanges  such  as  NF2.
opography
osterior  fossa  tumors  are  as  common  overall  as  supraten-
orial  tumors,  although  this  varies  depending  on  age.  Under
he  age  of  3  years  old,  supratentorial  tumors  predominate,
hereas  posterior  fossa  tumors  are  more  common  between
he  ages  of  3  and  11  years  old.  Subsequently,  the  incidence
f  supra-  and  infratentorial  tumors  is  identical  [2].  Tumors
re  located  in  the  midline  in  85%  of  cases  in  the  posterior
ossa  in  50%,  in  the  suprasellar  region  in  30%  and  in  the
ineal  region  in  5%.  This  is  a  risk  factor  for  meningeal  spread
nd  requires  a  complementary  spinal  MR  alongside  the  pre-
reatment  cerebral  MR  with  a  sagittal  T1-weighted  sequence
fter  gadolinium  injection.  Hemispheric  tumors  constitute
pproximately  15%  of  tumors  and  often  cause  epilepsy.  The
ite  provides  a  guide  as  the  type  of  tumor  (Table  1).  Poste-
ior  fossa  tumors  include  pilocytic  astrocytoma,  brain  stem
liomas,  medulloblastomas  and  ependymomas.  Malignant
liomas  should  be  considered  in  the  case  of  tumors  in  the
asal  ganglia  and  thalamus.  Malignant  gliomas  should  also  be
Table  1  Histology  of  childhood  brain  tumors  by  site.
Site  Site  
Posterior  fossa Cerebellum/vermis/V
Brain  stem  
Hemispheres Superﬁcial  
Deep  
Deep  gray  nuclei  
Intraventricular  
Suprasellar  
Pineal
ATRT: atypical teratoid rhabdoid tumor; DNET: dysembryoplastic neuro
i
t
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onsidered  in  the  deep  hemisphere  whereas,  peripherally,
umors  are  usually  benign,  such  as  the  DNET.
istological varieties
umors  are  classiﬁed  by  their  histological  type  and  grade
level  of  malignancy)  in  the  WHO  2007  classiﬁcation  [3].
rades  1  and  2  are  benign  tumors  and  grades  3  and
 are  malignant.  There  is  considerable  heterogeneity  in
istological  types  in  children,  both  benign  and  malig-
ant.  Primary  neuroepithelial  tumors  are  the  most  common
80%),  followed  by  craniopharyngiomas  and  germ  cell
umors  (3—5%).  The  commonest  of  the  neuroepithelial
umors  are  the  gliomas  (30—50%),  particularly  pilocytic
strocytoma  (20%  of  primary  neuroepithelial  tumors),
ollowed  in  descending  order  by  neuronal  and  mixed
lioneuronal  tumors,  which  account  for  approximately  19%
gangliogliomas,  DNET,  gangliocytomas,  dysplastic  cerebel-
ar  gangliocytoma),  embryonic  tumors,  which  account  for
7%  (medulloblastoma,  rhabdoid  tumors  or  ATRT,  primary
euroepidermal  tumors  or  CNS  PNET),  and  ependymomas
hich  account  for  approximately  11%.  The  pilocytic  astrocy-
omas,  medulloblastomas,  other  gliomas  and  ependymomasType
4  Pilocytic  astrocytoma
Medulloblastoma
Ependymoma
Rhabdoid  tumor  (ATRT)
Inﬁltrating  glioma
Circumscribed  glioma
Ganglioglioma
DNET
Pleomorphic  xanthoastrocytoma
Angiocentric  glioma
Oligodendroglioma
Embryonic  tumor
Malignant  glioma
Ependymoma
Malignant  glioma
Germinoma
Choroid  plexus  papilloma
Subependymal  giant  cell  astrocytoma
Craniopharyngioma
Optic  tract  glioma
Germinoma
Hypothalamic  hamartoma
Germinoma
Pineoblastoma
Papillary  pineal  gland  tumor
nal tumor; V4: fourth ventricle.
s  100  times  less  common  than  in  adults.  The  incidence  of
hese  different  histological  types  depends  on  age.  Under
 months  old,  teratomas  (30—50%),  pilocytic  astrocytomas
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aCerebral  tumors:  Speciﬁc  features  in  children  
(18—47%),  papillomas  (5—20%)  and  embryonic  tumors  pre-
dominate  [4,5].  Medulloblastoma  is  the  predominant  tumor
between  0  and  4  years  old,  pilocytic  astrocytoma  between  5
and  9  years  old,  high  grade  glioma  between  10  and  14  years
old,  and  suprasellar  tumors  between  5  and  19  years  old.
Genetic and molecular analysis
This  is  carried  out  as  a  complementary  process  to  histolog-
ical  examination  and  provides  a  better  assessment  of  the
diagnosis/prognosis  and  response  to  treatment.  Childhood
gliomas  have  different  molecular  and  genetic  features  to
those  in  adults  and  the  same  histological  type  can  have
different  histomolecular  features  depending  on  its  site  [6].
New aspects from the WHO (World Health
Organization) 2007
These  contain  additions  and  new  deﬁnitions  or  clariﬁcations
of  existing  diseases.  Several  tumor  groups  are  concen-
trated  in  the  pediatric  population  [7].  For  the  gliomas,
these  include  two  types  of  tumor,  pilomyxoid  astrocytoma
and  angiocentric  glioma.  Pilomyxoid  astrocytoma  (grade  2),
which  is  a  variant  of  pilocytic  astrocytoma,  is  character-
ized  by  local  recurrence  and  dissemination.  Angiocentric
glioma  (grade  1,  also  known  as  angiocentric  neuroepithe-
lial  tumor)  is  seen  in  children  and  young  adults  with  drug
resistant  epilepsy.  The  diagnosis  is  generally  made  on  his-
tological  examination.  Of  the  intraventricular  tumors,  the
atypical  choroid  plexus  papilloma  (grade  2)  is  characterized
by  increased  mitotic  activity,  which  is  not  differentiated
or  distinguished  from  a  papilloma  on  imaging  and  the
diagnosis  is  histological.  The  same  applies  within  the  hemi-
spheric  glioneuronal  tumors  to  papillary  glioneuronal  tumors
(PGNT),  which  are  generally  diagnosed  as  a  ganglioglioma
preoperatively.  In  the  pineal  region,  the  papillary  tumor  has
no  speciﬁc  imaging  features  and  the  diagnosis  is  also  his-
tological.  Amongst  the  embryonic  tumors,  medulloblastoma
with  extensive  nodularity  may  appear  similar  on  imaging  to
a  classical  medulloblastoma.  A  bunch-of-grapes  appearance
with  multiple  enhanced  nodules,  however,  is  characteris-
tic.  There  are  strong  genetic  predispositions  to  this  tumor
including  the  Fragile  X  syndrome  and  the  Li-Fraumeni  and
the  Gorlin  syndromes.  A  new  concept  of  the  embryonic
tumor  with  abundant  neuropil  and  true  rosettes  (ETANTR,
grade  4)  is  described  amongst  the  other  PNET.  This  is  a  hemi-
sphere  tumor  with  little  or  no  peritumoral  edema  and  weak
or  non-existent  enhancement.
Speciﬁc childhood brain tumors
In  infants,  these  are  the  desmoplastic  infantile  gangli-
oglioma  (grade  1)  and  the  atypical  rhabdoid  tumor  (ATRT)
(grade  4),  which  carry  a  poor  prognosis,  choroid  plexus  papil-
lomas  (grade  1)  and  teratomas.  Regardless  of  age,  the  other
tumors  which  are  unique  to  the  pediatric  population  are  the
pilocytic  astrocytoma  and  secretory  or  non-secretory  germ
cell  tumors.
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yndromic context
ccasionally,  speciﬁc  brain  tumors  may  occur  in  predis-
osing  syndromes  for  cancer:  NF1  (optic  tract  glioma),  NF2
meningiomas,  ependymomas),  tuberous  sclerosis  (giant  cell
ubependymal  tumor)  and  Gorlin  or  Li-Fraumeni  syndrome
medulloblastoma)  [8].
rognosis and treatment
hese  depend  on  the  histological  grade  and  type  and  on  the
taging  assessment  but  also  on  the  child’s  age.  Tumors  in
hildren  under  6  months  old  carry  a poor  prognosis  because
f  the  higher  incidence  of  malignancy,  larger  tumor  size  and
he  contraindication  to  radiotherapy  because  of  the  adverse
ffects  on  the  developing  brain  [9].
maging strategy
he  prognosis  and  treatment  of  brain  tumors  depends  on  the
istological  grade,  which  is  based  on  the  WHO  2007  criteria,
btained  after  biopsy  or  surgical  resection.  Generally,  treat-
ent  always  starts  with  surgery,  possibly  supplemented  by
hemotherapy  and/or  radiotherapy  depending  on  histologi-
al  type  and  grade  of  the  tumor.  It  is  important,  however,
o  obtain  an  accurate  preoperative  diagnosis  of  the  type
f  assumed  tumor  for  several  reasons.  It  is  ﬁrstly  essen-
ial  to  distinguish  between  true  tumors  and  pseudotumors
abscesses,  demyelinating  lesions,  encephalitis,  etc.),  which
ay  have  the  same  clinical  presentation  and  must  not  be
reated  surgically.  This  therefore  requires  multiparametric
R  [10,11]. Knowledge  of  the  type  and  grade  of  tumor
nables  surgery  (the  surgical  approach)  to  be  planned,  or
iopsies  to  be  guided  towards  the  most  malignant  parts  of
he  lesion.  In  a  presumed  benign  tumor,  surgery  may  be  less
ggressive  in  some  areas.  This  appears  to  be  essential  to  pre-
erve  the  child’s  future  neurological  outcome.  In  addition,
ome  tumors  are  not  treated  surgically  and  are  occasionally
ot  biopsied  because  of  their  site  (optic  tract,  brain  stem)
nd  the  diagnosis  and  choice  of  the  treatment  is  based  on
maging.
The  diagnostic  approach  includes  analysis  of  the  site  of
he  tumor  and  its  MR  and  CT  appearances,  incorporating
actors  relating  to  the  patient’s  clinical  ﬁndings  and  age.
erebral CT
ecause  of  its  ready  availability  and  speed,  CT  is  the  ﬁrst
nvestigation  to  be  performed  for  a  suspected  brain  tumor.
t  provides  a  positive  diagnosis  of  the  tumor  and  demon-
trates  whether  there  are  signs  of  brain  herniation,  which
etermine  the  urgency  of  surgery.  This  is  performed  in
nenhanced  mode  in  order  to  identify  hemorrhage  or  calciﬁ-
ations,  followed  by  contrast  enhancement.  These  features
re  difﬁcult  to  distinguish  on  MRI  [12]  even  using  T2*-
eighted  gradient-echo  and  susceptibility  (SWI)  weighted
maging.  CT  can  also  be  used  to  assess  tumor  cellularity,  a
yperdense  tumor  on  CT  reﬂecting  hypercellularity  and  very
ften  a  high  grade.
9 M.  Koob,  N.  Girard
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Box  1.  Imaging  features  of  the  main  childhood
tumors.
• Posterior  fossa  tumor
◦ Medulloblastoma:  low  ADC.
◦ Pilocytic  astrocytoma:  cyst  with  wall  contrast
enhancement,  high  ADC.
◦ Ependymoma:  extension  into  the  foramina  of
Luschka  and  Magendie.
• Suprasellar  tumor
◦ Craniopharyngioma:  a  hyperintense  cyst  on  T1WI,
calciﬁed.
◦ Germinoma:  solid  part  hypointense  on  T2
imagining  and  ADC  ≤  normal  brain.
◦ Pilocytic  astrocytoma:  high  choline  and  ADC  in  the
tissular  part.
• Pineal  tumors
◦ Germinoma:  hypointense  solid  part  on  T2WI  and
ADC  ≤  normal  brain.
◦ Teratoma:  cyst,  calciﬁcations,  tissular
components.
◦ Pineoblastoma:  very  low  ADC.
• Cortical  tumors
◦ Ganglioglioma:  calciﬁcations.
◦ DNET:  pseudocystic  and  cystic.
◦ Pleomorphic  xanthoastrocytoma:  superﬁcial  and
meningeal  enhancement.
◦ Angiocentric  glioma:  hyperintense  ring  on  T1WI.
• Intraventricular  tumors
◦ Choroid  plexus  papilloma:  intense  enhancement  in
the  ventricular  trigone.
◦ Subependymal  giant  cell  astrocytoma:  foramen  of
Monro,  tuberous  sclerosis.
• DGN  tumors:  gliomas,  germinoma.
• Hemispheric  tumors:  gliomas,  PNET  (low  ADC,
necrosis  and  hemorrhage),  ependymomas  (intra-
parenchymal,  close  to  the  ventricular  trigone).
DNET:  dysembryoplastic  neuronal  tumor;  PNET:
primary  neuroectodermal  tumor;  DGN:  deep  gray
•
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erebral MR
R  is  the  investigation  of  choice  for  the  preoperative  assess-
ent  of  a  childhood  brain  tumor.  It  includes  conventional
ultiplanar  imaging  and  advanced  techniques,  which  should
orm  part  of  the  initial  assessment  of  any  brain  tumor.  T1-
nd  T2-weighted  images  and  T1  images  with  gadolinium
nhancement  provide  a  morphological  and  staging  assess-
ent  of  the  lesion  but  appear  however  to  be  limited  in  their
bility  to  provide  a  more  detailed  characterization,  partic-
larly  in  terms  of  type  and  histological  grade.  Advanced
R  techniques  such  as  diffusion-weighted  imaging,  MR  spec-
roscopy  and  perfusion  MR  offer  a  functional  approach  which
mproves  the  characterization  of  cellularity,  vascular  hemo-
ynamics  and  tissue  metabolism,  improving  the  speciﬁcity
f  the  MR.
onventional  MR
he  imaging  protocol  should  be  adapted  to  take  account
f  the  site  of  the  tumor.  This  should  include  a  minimum  of
1-weighted  images  without  gadolinium,  T2-weighted  and
2*  and  FLAIR  images,  3D  volume  images,  or  at  least  2×  T1-
eighted  orthogonal  planes  after  gadolinium  enhancement.
nterpretation  should  include  an  analysis  of  the  boundaries
f  the  lesion  (inﬁltrating  or  expansive),  recording  its  site,
hether  it  is  unifocal  or  multifocal,  its  size  and  intensity  on
1,  T2  and  FLAIR  imaging,  whether  it  is  homogeneous  or  het-
rogeneous  in  appearance  and  whether  it  contains  necrosis
r  cysts  within  the  tumor,  macroscopically  abnormal  blood
essels,  contrast  enhancement,  edema  around  the  tumor,  a
pace-occupying  effect  or  meningeal  sites  of  disease.
The  overall  appearance  of  the  lesion  may  have  char-
cteristic  features  in  a  clearly  deﬁned  site  (a  pilocytic
strocytoma  in  the  posterior  fossa,  teratoma,  craniopharyn-
ioma,  etc.)  (Box  1).
Outside  of  these  conditions,  evidence  is  sought  to  support
he  benign  or  malignant  nature  of  the  lesion,  which  also
epends  on  tumor  site:
a hemorrhagic  tumor  with  peripheral  edema  containing
multiple  ectatic  vessels  is  suggestive  of  a  malignant  tumor
although,  in  a  recent  study,  edema  around  the  tumor  and  a
mass  effect  did  not  correlate  with  high  grade  malignancy
in  children,  as  edema  around  the  tumor  was  present  more
in  benign  (50%)  than  malignant  (31%)  tumors  [13];
on  T2-weighted  imaging  (T2WI),  hypercellular  tumors
(often  high  grade)  are  iso-/hypointense  compared  to  the
cortex,  whereas  paucicellular  tumors  (often  low  grade)
are  hyperintense  [14].  Tumor  microvasculature  is  also
clearly  seen  on  this  sequence;
the  level  of  contrast  enhancement  does  not  correlate
with  grade  of  tumor  in  children.  Pilocytic  astrocytoma  and
choroid  plexus  papilloma  enhance  intensely  after  gadolin-
ium  injection,  whereas  these  are  low  grade  tumors.
Conversely,  high  grade  tumors  such  as  the  anaplastic
astrocytoma,  medulloblastoma  or  ETANTR,  may  or  may
not  enhance;
intra-  and  peritumoral  cysts  which  are  isointense  with
CSF  (cerebrospinal  ﬂuid)  are  conventionally  characteris-
tic  of  pilocytic  astrocytomas,  gangliogliomas  (regardless
of  grade)  and  DNET  (in  which  generally  the  intratumoral
cysts  are  less  than  5  mm  in  size);
m
a
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tnuclei;  WI:  weighted  imaging.
necrosis,  which  is  not  isointense  with  the  CSF,  usually  seen
on  FLAIR  imaging,  is  rarer  than  in  adults,  as  the  tumors
tend  to  be  more  hypercellular  than  necrotic.  Embryonic
tumors  and  ependymomas  of  the  posterior  fossa  however
are  often  necrotic.  Necrosis,  however,  may  be  present
in  benign  tumors  (pilocytic  astrocytomas)  and  completely
absent  from  high  grade  hypercellular  tumors.
iffusion-weighted  MR
iffusion-weighted  imaging  should  be  used  routinely  as  this
s  sensitive  to  tumor  cellularity.  The  ADC  is  inversely  propor-
ional  to  cell  density  and  therefore  the  tumor  grade  [15].
ll  embryonic  tumors  (medulloblastoma,  rhabdoid  tumor
nd  PNET)  and  the  pineoblastoma  and  germ  cell  tumors,
ostly  seen  in  children,  are  malignant  (grade  4),  and  have
 very  low  ADC.  Diffusion-weighted  imaging,  therefore,
istinguishes  high  from  low  grade  tumors  in  children  in
he  absence  of  hemorrhage  [16],  both  on  a  supra-  and
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lCerebral  tumors:  Speciﬁc  features  in  children  
infratentorial  level  and  there  is  no  cutoff  value  between
grades  or  between  the  main  tumors  [12,16—19].  All  tumors
combined,  the  DNET  has  the  highest  value  and  embryonic
tumors  have  the  lowest  value.
Perfusion  MR
Dynamic  contrast-enhanced  T2*-weighted  perfusion  MRI
indirectly  reﬂects  the  density  and  vascular  proliferation
within  the  tumor  from  measurement  of  the  rCBV  (relative
cerebral  blood  volume).  The  rCBV  correlates  with  grade  of
glial  tumor  in  adults,  high  grade  tumors  having  a  higher
rCBV  than  low  grade  tumors  [20].  These  ﬁndings  cannot
perhaps  be  extrapolated  to  children  because  of  histolog-
ical  differences  between  the  tumors.  There  are  few  MR
perfusion  studies  on  cerebral  tumors  in  speciﬁc  pediatric
populations  [21,22],  probably  because  of  technical  injec-
tion  problems.  It  is,  however,  entirely  possible  to  perform
a  perfusion  MR  in  young  children  using  small  catheters  and
injection  rates  of  0.8  to  1  ml/s  [22],  or  using  manual  injec-
tion  [23].
An  alternative  MR  perfusion-weighted  technique  (arte-
rial  spin  labeling)  is  reported  to  distinguish  high  from
low  grade  brain  tumors  in  children,  but  not  the  differ-
ent  histological  types  [24].  Maximum  rTBF  (relative  tumor
blood  ﬂow)  is  higher  in  high  grade  compared  to  low  grade
tumors.
MR  spectroscopy
MR  spectroscopy  (MRS)  is  used  to  study  tumor  metabolism.
The  main  features  of  malignant  tumors  are  elevated  choline
(Cho)  levels,  attributed  to  cell  membrane  proliferation  and
reduced  N-acetylaspartate  (NAA)  and  creatine  (Cr)  levels
attributed  to  edema  and  necrosis  [25].  A  lactate  (Lac)  sig-
nal  is  often  seen  in  malignant  rather  than  low  grade  lesions
[26],  due  to  metabolic  acidosis  within  tumor  tissue.  Necrosis
is  reﬂected  by  an  increase  in  Lac/Lip  (lipid)  resonance  asso-
ciated  with  a  fall  in  all  of  the  other  metabolites  [27]. The
highest  ratios  of  Cho/Cr  and  Cho/NAA  are  seen  in  aggressive
tumors  and  diffuse  brain  stem  gliomas.
Some  spectroscopic  features  of  different  pediatric  brain
tumors  are  seen.  The  benign  pilocytic  astrocytoma  has  a
high  Lac  level  as  a  result  of  still  poorly  understood  biochem-
ical  metabolism.  The  Cho/NAA  and  Cho/Cr  ratios  are  raised
despite  the  fact  that  these  lesions  are  benign  [4,28,29].  In
children,  therefore,  raised  choline  is  not  synonymous  with
a  malignant  tumor.  In  type  1  neuroﬁbromatosis,  the  Cho/Cr
ratio  helps  to  distinguish  between  local  intraparenchymal
involvement,  which  is  hyperintense  on  T2  imaging,  from
glial  tumors  and  healthy  parenchyma  [30]  in  children.  The
glioblastomas  have  the  highest  alanine  glutamine-glutamate
and  glycine  concentrations  [31].  Myoinositol  levels  have
been  shown  to  be  raised  in  choroid  plexus  papilloma  [29,32].
This  is  a  benign  lesion,  particularly  compared  to  the  malig-
nant  choroid  plexus  carcinoma,  in  which  choline  is  increased
[33].  Myoinositol  is  also  raised  in  ependymoma  [4].  Taurine
concentrations  are  increased  in  primary  neuroectodermal
tumors  (PNET)  [18,33]  and  citrate  is  found  in  malignant  inﬁl-
trating  pontine  astrocytomas  [4].  Germ  cell  tumors  have
high  levels  of  glutamine-glutamate.
Taken  in  isolation,  each  technique  appears  to  be
limited  in  distinguishing  and  grading  tumors.  A  multimodal
o
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R  approach  therefore  appears  to  be  essential  in
he  preoperative  assessment  of  a  tumor  [34]  in  order
o  improve  its  characterization.  Unlike  in  adults,  few
arge  pediatric  series  are  available  [18,21]  as  these
umors  are  less  common  and  are  histologically  more
iverse.
liomas
ilocytic astrocytoma
his  is  the  commonest  tumor  in  children  and  accounts  for
0%  of  posterior  fossa  tumors  [35].  It  is  a  benign  (grade  1),
learly  circumscribed  and  slow-growing,  often  small  tumor,
ound  between  the  ages  of  5  and  13  years  old  [36].  Surgery  is
urative  without  recurrence  if  completely  excised.  Sixty  to
0%  of  pilocytic  astrocytomas  are  located  in  the  cerebellum,
sually  in  the  cerebellar  hemispheres  or  in  the  vermis.  The
ther  sites  involved  are  the  hypothalamic-pituitary  region,
halamus,  brain  stem  and,  far  less  commonly,  the  cerebral
emispheres  and  ventricles  [37].  Its  most  typical  appear-
nce  is  a  cyst  with  an  intensely  enhancing  mural  nodule,
hich  is  only  seen  in  50%  of  cases  (Fig.  1).  This  is  not
peciﬁc  for  a  pilocytic  astrocytoma  and  may  be  seen  in  gan-
liogliomas  and  pleomorphic  xanthoastrocytomas.  PA  may
resent  as  a  solid  lesion  with  a  cystic-necrotic  center  in  40
o  45%  of  cases,  or  as  a  purely  solid  lesion  in  10%  of  cases
36]. The  solid  portion  of  the  tumor  is  hypodense  on  CT  and
ccasionally  calciﬁed.  It  is  iso-/hypointense  on  T1WI  and
yperintense  on  T2WI.  It  enhances  intensely  with  contrast,
ccasionally  heterogeneously  on  MR.  On  diffusion-weighted
maging  the  ADC  is  increased  as  the  tumor  is  paucicellular.
n  perfusion  imaging  the  rCBV  is  low,  with  a  curve  rising
bove  the  baseline,  reﬂecting  blood-brain  barrier  disruption
38]. This  cyst  has  occasionally  a  high  protein  or  hem-
rrhagic  content  and  the  cyst  wall  occasionally  enhances
omogeneously,  often  if  the  adjacent  cerebral  parenchyma
s  inﬁltrated  or  if  hemorrhage  has  occurred  within  the  cyst
36].
The  optic  tract  glioma  is  a  pilocytic  astrocytoma,  which
evelops  in  the  region  of  the  hypothalamus,  optic  chi-
sma  or  optic  nerves  and  accounts  for  5%  of  childhood
umors  [24].  Fifteen  percent  of  patients  with  NF1  develop
n  optic  tract  glioma  (OTG)  and  a  third  of  patients  with
ptic  nerve  pilocytic  astrocytoma  have  NF1  [39],  whereas
osterior  visual  tract  involvement  is  usually  seen  outside
f  NF1.  OTG  is  characterized  by  visual  and  endocrine  dis-
urbances  (early  puberty).  It  presents  as  a multilobulated
vular  or  round  mass,  with  superior  extension  into  the
hird  ventricle,  inferior  ventricle  or  sella  turcica,  posteri-
rly  into  the  interpeduncular  fossa  and  anteriorly  into  the
nterior  cerebral  fossa.  It  develops  along  the  anterior  and
osterior  optic  tract  but  it  is  occasionally  located  in  the
ypothalamic-chiasmal  region.  Meningeal  spread  is  rare  and
sually  occurs  after  surgery.  Contrast  enhancement  varies
nd  is  occasionally  only  seen  on  the  peripheral  part  of  the
esion.The  pilomyxoid  astrocytoma  is  a  more  aggressive  form
f  disease  (grade  2)  [40]  and  is  typically  found  in  the
uprasellar  region  in  young  children.  It  should  be  consid-
red  in  infants  or  young  children,  particularly  if  the  lesion  is
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Figure 1. Pilocytic astrocytoma in a 6-year-old child; a: axial T2-weighted image: cystic tumor lesion with a wall tissue nodule in the
right cerebellar hemisphere; b: axial T1-weighted image after gadolinium injection: intense enhancement in the solid part of the lesion;
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s: axial ADC map: the tissular part of the lesion has a high ADC val
AA, and lactate present.
emorrhagic  (25%  of  cases)  with  intense  contrast  enhance-
ent  [7].
ther gliomas
leomorphic  xanthoastrocytoma  is  a  grade  2  tumor,  which
s  occasionally  anaplastic  (grade  3),  and  is  usually  seen  in
dolescents  and  young  adults  over  20  years  old.  It  is  a
ortical  tumor  which  is  located  in  the  temporal  (49%)  pari-
tal,  frontal  or  occipital  regions  [7]  and  causes  epilepsy.
t  is  seen  as  a  cyst  with  a  peripheral  wall  nodule  and
eningeal  or  dural  attachment  in  2/3  of  cases  or  occasion-
lly  as  a  purely  solid  lesion  [41].  Calciﬁcations  are  rare.
he  adjacent  cranial  vault  may  become  eroded.  The  solid
eripheral  portions  of  the  tumor  are  isointense  on  T2WI  and
nhance  with  gadolinium  (the  enhancement  is  described  as
‘meningocerebral’’).
rade  2  glioma  (diffuse  ﬁbrillary  astrocytoma)
rade  2  glioma  (diffuse  ﬁbrillary  astrocytoma)  (Fig.  2)
ostly  develops  in  the  frontal  and  temporal  lobes  and  is  a
omogeneous  inﬁltrative  lesion  without  surrounding  edema
r  hemorrhage.  It  is  hypodense  on  CT,  hypointense  on  T1WI,
nd  hyperintense  on  T2WI,  and  does  not  enhance  with
adolinium.
o
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a: monovoxel MR spectroscopy (PRESS, TE 135): raised choline, low
naplastic  gliomas  (astrocytomas,
ligoastrocytomas)
naplastic  gliomas  (astrocytomas,  oligoastrocytomas)  are
rade  3,  and  have  the  same  appearance,  although  with  a
ore  heterogeneous  image.  Myoinositol  appears  lower  than
n  the  low  grade  gliomas  on  MRS  [4]  (Fig.  3).
lioblastomas  (grade  4)
lioblastomas  (grade  4)  are  rare  in  children.  This  is  a  hem-
rrhagic  necrotic  lesion,  which  is  enhanced  after  gadolinium
njection.  Choline  is  increased,  lactate  and  lipids  are
resent,  the  rCBV  is  increased  and  the  ADC  is  low  [42].  These
alignant  gliomas  are  also  seen  in  the  deep  gray  nuclei.
ocal  anaplastic  sites  are  suggested  by  a  hemorrhagic  area
r  by  contrast  enhancement  [43].  It  is  occasionally  difﬁcult
o  formally  distinguish  the  different  grades  of  gliomas  on
R.
ligodendrogliomas
he  oligodendrogliomas  are  rare  grade  2  tumors  account-
ng  for  under  2.5%  of  childhood  tumors  [44],  which  are
een  around  adolescence.  More  aggressive  anaplastic  forms
f  the  tumor  (grade  3)  are  seen.  They  are  located  in  the
rontal  (50—85%)  and  temporal  [2]  regions  in  the  cortex
nd  adjacent  white  matter,  or  in  the  central  gray  nuclei
nd  thalamus,  and  they  carry  a  poorer  prognosis.  They
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Figure 2. Diffuse grade 2 astrocytoma in a 13-year-old child; a: axial FLAIR image: inﬁltrating temporal lobe white matter lesion, hyper-
intense on FLAIR; b: axial ADC map: increased ADC within the lesion; c: T1-weighted axial image after gadolinium injection: the lesion is
hypointense and does not enhance with gadolinium.
Figure 3. Grade 3 anaplastic astrocytoma in a 12-year-old child; a: axial T2-weighted image: hyperintense lesion in the left thalamus on
T2-weighted imaging; small hypointense area of hemorrhage on T2, suggesting an anaplastic component; b: axial ADC map: area of reduced
ADC within the lesion which, overall, displays a high ADC suggesting an anaplastic area; c: T1-weighted axial image after gadolinium
injection: contrast enhancement around the area of hemorrhage; d: spectroscopic imaging (CSI, TE 135): the contrast-enhanced area has a
large increase in the choline/creatine ratio.
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Figure 4. Grade 2 left frontal oligodendroglioma in a 17-year-old child; a: axial T2-weighted image: inﬁltrating lesion in the cortex and
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nhance and contains small cysts.
re  characterized  by  epilepsy,  RICP  and  neurological  deﬁcit
44].  The  lesion  is  hypodense  with  calciﬁcations  in  40%  of
ases  (fewer  than  in  adults)  [45].  The  signal  is  hypointense
n  T1-weighted  and  hyperintense  on  T2-weighted  imaging,
ccasionally  with  small  cysts  (Fig.  4).  Contrast  enhancement
s  rare  in  children,  as  is  the  mass  effect  or  the  edema  [46],
part  from  anaplastic  tumors.  The  ADC  is  increased.  The
ifferential  diagnosis  is  with  dysplasias  and  DNET.
ngiocentric  glioma
ngiocentric  glioma  is  a  cortico-subcortical  lesion,  which  is
haracterized  by  partial  refractory  partial  epilepsy  in  chil-
ren  between  2  and  14  years  old.  It  is  located  in  the  temporal
egion  in  38%  of  cases,  frontal  in  25%,  parietal  in  10%  and
ccipital  in  8%  [47].  The  grade  1  lesion  may  remain  stable
r  increase  in  size  slowly.  It  is  clearly  delineated,  does  not
t
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o
igure 5. Angiocentric glioma in a 10-year-old child; a: FLAIR axial i
yperintense on FLAIR imaging; b: sagittal T1-weighted image without 
ing, hyperintense on T1-weighted imaging.T1-weighted image after gadolinium injection: the lesion does not
nhance  and  is  located  in  the  cortex  with  extension  towards
he  ventricle.  The  tumor  is  hypointense  on  T1WI  and  hyper-
ntense  on  T2WI  and  FLAIR,  without  contrast  enhancement.
he  most  characteristic  features  are  reported  to  be  exten-
ion  of  the  lesion  towards  the  lateral  ventricles  on  T2WI  and
LAIR  and  a  hyperintense  cortical  rim  on  T1WI  (Fig.  5)  [48].
iant  cell  astrocytoma
iant  cell  astrocytoma  is  a  benign  grade  1  intraventricular
esion  which  develops  close  to  the  foramen  of  Monro,  and
ay  produce  acute  obstructive  hydrocephalus.  It  is  almost
nly  seen  in  tuberous  sclerosis,  in  15%  of  patients  under
he  age  of  20  years  old  [45].  Other  stigmata  of  the  dis-
ase  include:  cortical  tubers,  subependymal  nodules  and
adial  migration  lines  in  the  white  matter.  It  presents  as  an
ccasional  multifocal  mass  containing  calciﬁcations  which
mage: right frontal lesion involving the cortex and white matter,
contrast injection: the lesion displays a characteristic peripheral
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are  hypo-/isointense  on  T1  and  iso-/hyperintense  on  T2-
weighted  imaging,  enhancing  strongly  with  gadolinium.  It
should  be  distinguished  from  a  subependymal  nodule,  from
which  it  may  develop,  from  its  size,  which  is  over  10/12  mm.
Tumor  size  can  be  reduced  by  treatment  with  everolimus
[49].
Brain  stem  glioma
Brain  stem  glioma  accounts  for  10  to  20%  of  childhood  cere-
bral  tumors  and  20  to  25%  of  infratentorial  tumors.  Two
types  of  presentation  are  found  on  MR,  which  carry  a  dif-
ferent  prognosis:  diffuse  (the  commonest)  and  focal  (better
prognosis)  [50].
Diffuse  intrinsic  pontine  glioma
The  diffuse  intrinsic  pontine  glioma  accounts  for  60  to  80%
of  pontine  tumors  and  75%  are  found  before  the  age  of  10
years  old  [35].  These  have  a  very  poor  prognosis,  with  a  life
expectancy  of  no  more  than  one  year.  Clinical  signs  are  a
combination  of  cranial  nerve  involvement,  particularly  VI
and  VII,  a  pyramidal  syndrome  and  ataxia.  These  are,  in
general,  grade  2  ﬁbrillary  gliomas,  although  the  tumors  are
rarely  biopsied  because  of  the  risk  of  the  complications.
They  are  difﬁcult  to  see  on  CT  and  are  only  indicated  by
the  mass  effect,  which  they  produce  on  the  fourth  ventri-
cle.  On  MR,  they  appear  as  a  large  inﬁltrating  pontine  lesion
(Fig.  6),  which  may  extend  vertically,  into  the  cerebellum
and  anteriorly,  surrounding  the  basilar  artery.  They  are  hypo-
/isointense  on  T1  and  hyperintense  on  T2  and  FLAIR  imaging,
show  little  or  no  enhancement  with  gadolinium  [51],  and
have  a  high  ADC  [51].  Transformation  into  a  higher  grade
(3  and  4)  is  reﬂected  by  development  of  contrast  enhance-
ment,  hemorrhage,  an  area  of  reduced  ADC,  raised  rCBV
[22],  or  on  MRS  by  an  increase  in  choline  and  the  presence
of  lipids.
Focal  tumors
Focal  tumors  are  located  in  the  mesencephalon,  medulla
or  cervico-medullary  junction.  They  are  usually  low  grade
tumors  (pilocytic  astrocytoma  or  ganglioglioma),  which  are
identical  in  appearance  to  those  in  other  sites.  They  may
be  intrinsic  or  dorsal  exophytic  in  the  fourth  ventricle  or
t
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Figure 6. Anaplastic brain stem glioma in a 15-year-old child; a: T2
hyperintense of T2-weighted imaging, causing compression of the four
paucicellular nature of the lesion; c: axial T1-weighted axial image afte973
erimedullary  cisterns,  or  may  be  anterolateral  [50,52].
urgery  is  often  partial  although  it  still  has  a  good  prog-
osis.
lioneuronal tumors
anglioglioma
his  is  an,  often  benign,  grade  1  tumor  accounting  for  1
o  4%  of  childhood  brain  tumors  and  40%  of  tumors  causing
pilepsy.  The  most  common  clinical  presentation  is  refrac-
ory  complex  partial  epilepsy  and  the  tumor  is  10  times
ore  common  in  children  than  in  adults  [53]. The  major-
ty  of  cases  are  seen  between  the  ages  of  10  and  20  years
ld  [54]. They  are  located  in  the  cortex,  in  80%  of  cases
n  the  temporal  regions  and  in  12%  of  cases  in  the  frontal
egions  and  present  as  a  solid  mass  (43%),  cyst  (5%),  or
ixed  lesion  (52%)  (Fig.  7) [53].  Highly  suggestive  calciﬁ-
ations  are  seen  in  50%  of  cases.  Scalloping  of  the  adjacent
ranial  vault  may  occur,  although  no  edema  is  seen  around
he  lesion.  CT  appearances  vary  and  on  MR  the  lesion
nlarges  a  gyrus  and  affects  the  cortex.  The  solid  part  of
he  lesion  appears  iso-/hypointense  on  T1  and  hypointense
n  T2WI.  Contrast  enhancement  is  variable  in  intensity,  and
ccasionally  peripheral,  and  is  seen  in  60%  of  cases.  The
DC  is  increased  and  the  rCBV  appears  higher  than  in  low
rade  gliomas  [45]. Multimodal  MRI  is  required  in  refrac-
ory  epilepsy  to  distinguish  a  ganglioglioma  from  a  DNET  and
ocal  cortical  dysplasia  because  of  its  potential  for  anaplas-
ic  transformation  (grade  3).  rCBF,  rCBV  and  choline  are
igher  in  gangliogliomas  and  the  creatine  is  lower  [55].
esmoplastic  infantile  ganglioglioma
esmoplastic  infantile  ganglioglioma  is  a  speciﬁc  form  of
anglioglioma  seen  in  children  under  6  months/1  year  old.
t  causes  macrocrania,  epilepsy  and  focal  neurological  signs.
t  is  usually  located  in  the  frontal  or  parietal  region  and
resents  as  a  large,  solid  cystic  lesion.  The  solid  portion  of
he  lesion  is  attached  to  the  dura  and  is  hypointense  on  T2WI
ith  a low  ADC,  enhancing  intensely  with  contrast.  Edema
ay  be  present,  although  calciﬁcations  are  not  seen.  It  has
 good  prognosis.
-weighted sagittal image: inﬁltrating lesion in the pons which is
th ventricle; b: axial ADC map: the ADC is increased due to the
r gadolinium injection: the lesion does not enhance.
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Figure 7. Right temporal ganglioglioma in a 13-year-old child; a: axial T2-weighted image: right temporal solid cystic lesion with a
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meripheral tissue portion, which is hyperintense on T2-weighted ima
ontrast enhancement in the tissular part of the lesion.
ysembryoplastic neuronal tumor (DNET)
his  is  a  grade  1  neuroglial  tumor,  which  accounts  for  14%
f  epilepsy-related  tumors  and  is  seen  before  the  age  of  20
ears  old.  Surgery  can  cure  the  epilepsy  and  recurrences
re  rare.  It  is  located  in  the  cortical/subcortical,  temporal
62%)  or  frontal  (31%)  regions  [54].  Occasional  intraventric-
lar  tumors  are  seen,  together  with  those  which  develop
n  the  deep  gray  nuclei  and  thalamus.  The  most  typical
istological  appearance  is  the  speciﬁc  glioneuronal  compo-
ent.  According  to  the  Daumas-Duport  classiﬁcation,  there
re  three  histological  types  of  the  tumor:  simple,  com-
lex  and  non-speciﬁc.  The  simple  form  is  associated  with
seudocystic  appearances,  the  complex  form  with  pseudo-
ulticystic  appearances,  and  the  non-speciﬁc  form  with
omogeneous  or  heterogeneous  nodules  or  pseudodysplasia
56].  The  tumor  is  clearly  delineated,  triangular  in  shape,
ith  no  edema  and  occasionally  produces  scalloping  on  the
ranial  vault  (Fig.  8)  [57].  It  appears  multilobulated  with
m
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igure 8. Right internal temporal DNET in a 15-year old child; a: coron
ith microcysts present; b: axial ADC map: the ADC of the lesion is ex
icronodular contrast enhancement in the lesion.; b: sagittal T1-weighted image after gadolinium injection: intense
epta  made  up  of  multiple  pseudocysts.  Calciﬁcations  are
een  in  a  third  of  cases  [54]. The  image  is  hypointense  on
1,  and  hyperintense  on  T2WI  and  FLAIR  images,  with  no
dema  or  space-occupying  effect  apart  from  local  expan-
ion  of  a  gyrus.  Contrast  enhancement  is  seen  in  21  to  50%
f  cases  and  is  nodular,  annular  or  heterogeneous.  A  raised
yoinositol  and  insigniﬁcant  fall  in  NAA  have  been  reported
n  MRS  [58].  The  images  of  DNET  or  contrast  enhancement
ay  change  spontaneously  over  time  [53].
isseminated glioneuronal tumor
his  is  a rare  tumor  with  fewer  than  30  cases  described  in
he  literature,  grouped  under  the  term  glioneuronal  tumor
r  diffuse  meningeal  neuroepithelial  tumor  [59—61].  It  is
ade  up  of  glioneuronal  oligodendrocytes-like  cells  which
nﬁltrate  the  meninges  and  is  believed  to  be  a  lesion  related
o  the  glioneuronal  tumors  (not  yet  listed  in  the  WHO  clas-
iﬁcation).  MR  appearances  are  very  characteristic,  with
al FLAIR image: the lesion displays a hyper- and hypointense image
tremely high; c: axial T1-weighted image after gadolinium: slight
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diffuse  cerebral  and  spinal  meningeal  contrast  enhancement
associated  with  multiple  cystic  lesions  within  the  ventricles
and  in  the  cerebral  meningeal,  particularly  cerebellar  and
spinal,  spaces.  It  often  presents  with  tetraventricular  hydro-
cephalus  and  headaches,  RICP  and  ataxia.  Initial  biopsies  are
often  negative  with  no  abnormal  cells  on  lumbar  puncture.  It
grows  slowly  with  a  gradual  increase  in  cyst  size.  Treatment
is  with  a  combination  of  chemotherapy  and  radiotherapy.
Embryonic tumors
Medulloblastoma
Medulloblastoma  is  the  commonest  malignant  childhood
brain  tumor  (grade  4)  (20—30%)  [62],  and  accounts  for  40%
h
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Figure 9. Medulloblastoma in a 2-year-old child; a: axial CT image: 
tricle; b: axial T2-weighted MR: the mass displays an iso-hypointense si
hypercellularity of the tumor; d: axial T1-weighted image after gadolini
T1-weighted image after gadolinium injection: contrast enhancement ar975
f  posterior  fossa  tumors.  Together  with  PNET  and  rhabdoid
umors  it  is  one  of  the  highly  aggressive  embryonic  tumors.
t  is  usually  seen  before  the  age  of  7  years  old,  with  a  peak
ncidence  at  4  years  old,  and  is  more  common  in  boys.
It  is  located  in  the  cerebellum  in  94.4%  of  cases,  on
he  midline  in  75%.  It  is  a  clearly  delineated  tumor,  which
evelops  in  the  fourth  ventricle  from  the  inferior  vermis,
ausing  hydrocephalus  (Fig.  9) [62].  It  may  occasionally
xtend  into  the  foramen  of  Luschka  and  the  cerebellopon-
ine  angle,  like  an  ependymoma.  Spinal  meningeal  tumors
re  found  in  30  to  40%  of  cases  at  the  time  of  diagnosis.  Five
istological  subtypes  are  seen,  with  or  without  N-Myc  ampli-
cation,  which  carry  different  prognoses:  classical  (65—80%
f  cases),  large  cell  anaplastic  (4—5%,  very  aggressive  and
hyperdense, partially calciﬁed tumor mass within the fourth ven-
gnal to gray matter; c: axial ADC map: the ADC is low due to the
um injection: the lesion enhances intensely; e: spinal MR, sagittal
ound the spinal cord representing leptomeningeal metastases.
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etastatic),  extensive  nodularity  (5%,  before  1—3  years  old
ith  multinodular  appearance),  and  desmoplastic  (15—25%,
emispheric,  occurring  in  adolescence  and  carrying  a  good
rognosis)  [35,36].
Medulloblastomas  are  hyperdense  tissue  masses  on  CT
ecause  of  their  hypercellularity  [28]  and  calciﬁcations
re  seen  in  20  to  40%  of  cases.  On  MR  the  lesion
ppears  hypointense  on  T1-weighted  and  iso-/hypointense
n  T2-weighted  and  FLAIR  imaging.  Small  peripheral  cysts
50%)  and  necrotic  areas  are  commonly  seen.  Cysts  are
ore  common  in  classical  medulloblastoma  and  desmo-
lastic  medulloblastoma  [63].  These  enhance  strongly  with
ontrast,  although  the  enhancement  is  occasionally  het-
rogeneous  or  absent.  The  most  reliable  indicator  in  the
iagnosis  is  the  ADC,  which  is  low  for  both  tumor  and  related
eningeal  metastases  because  of  the  tumor  hypercellular-
ty.  Occasional  cases  are  seen  with  a  high  ADC  [64]. MRS
hows  features  of  an  aggressive  tumor,  with  high  choline,
ipids  and  taurine  resonancies  [18].  The  rCBV  is  high  on  per-
usion  MR.
habdoid tumor
habdoid  tumors  or  ATRT  (atypical  teratoid  rhabdoid
umors)  are  rare  tumors  with  a  very  poor  prognosis  which
re  found  in  children  under  3  years  old  [65].  A  charac-
eristic  mutation  in  the  SMARCB1/INI1  gene  is  seen  in  76%
f  cases,  which  predisposes  to  the  formation  of  intra-  and
xtracerebral  rhabdoid  tumors  [5].  They  may  be  found  in  the
osterior  fossa  (60—70%)  and/or  in  the  supratentorial  region
hemispheres,  pineal  region),  may  be  intra-  or  extra-axial
nd  are  often  multifocal.  These  are  large  calciﬁed,  hem-
rrhagic,  necrotic  tumors  surrounded  by  extensive  edema,
ith  peripheral  cysts  and  meningeal  metastases  [66]. The
ommonest  site  is  intra-axial,  away  from  the  midline.  In
xtra-axial  tumors,  the  cerebellopontine  angle  is  often
nvolved  (Fig.  10).  They  are  heterogeneous  tumors  which
re  hyperdense  on  CT,  and  hypointense  on  T2-weighted  MR,
ith  variable  contrast  enhancement.  Rhabdoid  tumors  and
edulloblastomas  have  the  same  appearances  on  MR,  with
 low  ADC,  although  rhabdoid  tumors  occur  in  younger  chil-
ren  (under  3  years  old),  affect  the  cerebellopontine  angle
E
E
p
igure 10. Rhabdoid tumor (ATRT) in a 9-month-old child; a: axial T2-
opontine angle, which is iso- and hyperintense on T2-weighted imaging
DC map: the ADC is reduced within the lesion, reﬂecting its hypercellul
eterogeneous enhancement of the lesion.M.  Koob,  N.  Girard
nd  often  contain  hemorrhage  [67].  Treatment  is  a  combi-
ation  of  surgery  and  radiotherapy.
Supratentorial  tumors  are  larger  in  size,  more  contain
ysts,  and  have  central  necrosis  with  a  thick  layer  of
eripheral  contrast  enhancement.  These  tumors  are  found
redominantly  in  the  frontal  lobes  and  are  also  less  prone
o  metastasize  [68].
entral nervous system (CNS) PNET tumors
hese  are  rare,  very  aggressive,  poor  prognosis  tumors
een  in  children  under  5  years  old.  They  are  located
n  the  supratentorial  region  or  in  the  brain  stem.  Five
ubtypes  of  PNET  are  recognized:  classical,  CNS  neuro-
lastoma,  CNS  ganglioneuroblastoma,  medulloepithelioma
nd  ependymoblastoma  [3]. They  are  large  locally  invasive
umors  and  are  associated  with  leptomeningeal  metastases
n  40%  of  cases  [45].  They  are  hyperdense  and  contain  cal-
iﬁcations,  necrosis,  hemorrhage  and  enhance  variably  with
ontrast.  The  ADC  is  low  and  MRS  shows  signs  of  an  aggressive
umor.
TANTR  (embryonal  tumor  with  abundant  neuropil
nd true  rosettes)
TANTR  (embryonal  tumor  with  abundant  neuropil  and  true
osettes)  is  a  speciﬁc  form  of  PNET  occurring  before  the
ge  of  4  years  old  (particularly  under  two  years  old)  and
ore  commonly  in  girls.  It  is  predominantly  found  in  the
upratentorial  region,  in  the  frontal  and  temporal  lobes.
hey  are  large,  solid,  clearly  delineated  tumors  adhering
o  the  dura  mater  [69],  with  limited  peritumoral  edema,
lthough  a  space-occupying  effect  is  seen.  Hemorrhage  does
ot  occur,  although  microcalciﬁcations,  cysts  and  blood  ves-
els  are  found  in  the  tumor.  They  do  not  enhance  particularly
ith  contrast,  the  ADC  is  low  and  meningeal  metastases  are
ommon  [70].pendymoma
pendymomas  account  for  6  to  10%  of  all  tumors  and  15%  of
osterior  fossa  tumors  [71].  Seventy  percent  of  the  tumors
weighted image: heterogeneous tumor lesion in the right cerebel-
, containing areas of necrosis and cysts within the tumor; b: axial
arity and high grade; c: axial T1-weighted image after gadolinium:
Cerebral  tumors:  Speciﬁc  features  in  children  977
Figure 11. Anaplastic ependymoma in a 4-year-old child; a: sagittal T1-weighted image: tumor mass in the fourth ventricle extending
towards the posterior surface of the cervical cord; b: axial ADC map: the tumor mass extends into the left cerebellopontine angle, through
the foramen of Luschka. The ADC is intermediary; c: axial T1-weighted image after gadolinium injection: heterogeneous enhancement of
the lesion with annular contrast uptake; d: monovoxel MR spectroscopy (PRESS, TE 30): raised myoinositol, low NAA, and lactate present.
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sare  infratentorial  [72],  in  which  case,  they  are  malignant
(grade  3,  anaplastic)  and  are  seen  particularly  in  children
under  3  years  old.  They  arise  from  the  ependymal  cells  of  the
fourth  ventricle,  the  foramen  of  Luschka,  or  from  the  lateral
ventricles.  The  most  characteristic  appearance  of  the  tumor
is  its  morphology  and  extension  (Fig.  11),  showing  a mass
growing  inside  the  fourth  ventricle  extending  into  the  foram-
ina  of  Magendie  and  Luschka  towards  the  cerebellopontine
angles,  the  cisterna  magna  and  the  spinal  canal,  surround-
ing  vessels  and  nerves.  Less  commonly,  the  tumor  grows  from
the  foramen  of  Luschka  into  the  cerebellopontine  angle.  On
CT  the  tumor  is  iso-/hyperdense.  Punctiform  calciﬁcations
are  seen  in  50%  of  cases,  with  hemorrhages  in  10%  [72]. MR
appearances  vary  and  are  heterogeneous,  iso-/hypointense
on  T1-weighted,  and  hyperintense  on  T2-weighted  and  FLAIR
imaging,  and  contain  cysts  and  necrosis.  Contrast  enhance-
ment  is  heterogeneous  but  may  be  absent  [72].  The  ADC
varies  between  that  of  a  medulloblastoma  and  a  pilocytic
astrocytoma  [18].  The  rCBV  also  varies.  Choline,  myoino-
sitol,  glutamate-glutamine  and  lactate  are  increased,  and
NAA  is  reduced  on  MRS.  Myoinositol  is  reported  to  be  higher
in  anaplastic  (grade  3)  ependymomas  [4].  Meningeal  metas-
tases  are  only  seen  in  10  to  12%  of  cases  at  the  time  of
I
c
I
diagnosis,  particularly  with  anaplastic  tumors  [36]  but  are
ound  more  commonly  during  follow-up  over  time.
Ependymomas  are  located  in  the  supratentorial  region
n  30%  of  cases,  when  they  are  often  benign  (grade  2).
ntraventricular  localizations  (30%)  are  less  common  than
ntraparenchymal  tumors  (70%),  in  the  parietal  or  tem-
oroparietal  lobe  alongside  the  ventricular  trigone.  This  is  a
ell-delineated  tumor  with  heterogeneous  appearances  and
ysts.  Calciﬁcations  are  present  in  a  third  to  50%  of  cases
72].
erm cell tumors
erminoma
his  grade  4  tumor  accounts  for  1  to  2%  of  childhood  brain
umors  [73,74].  The  most  common  site  is  pineal  (57%),  and
uprasellar  (32%),  followed  by  the  deep  gray  nuclei  (9%).
t  tends  to  affect  boys  between  10  and  18  years  old.  Bifo-
al  suprasellar  and  pineal  tumors  are  seen  in  15%  of  cases.
t  presents  with  signs  of  raised  intracranial  pressure,  visual
isturbance  or  ataxia.  CT  shows  a  hyperdense  calciﬁed  mass.
978  M.  Koob,  N.  Girard
Figure 12. Suprasellar germinoma in a 16-year-old child; a: sagittal T1-weighted image: the tissular mass has developed in the suprasellar
region and interpeduncular cistern. It is isointense on T1-weighted imaging. The normal T1 signal hyperintensity in the posterior pituitary
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as not seen; b: axial ADC map: The ADC is low, unlike the pilocytic a
adolinium injection: heterogeneous enhancement in the lesion; d
ecause of its hypercellularity.
ppearances  are  isointense/hypointense  on  T1-weighted,
nd  iso-/hyperintense  on  T2-weighted  imaging.  Cystic  or
ecrotic  hemorrhagic  areas  may  be  seen,  particularly  in
arge  tumors.  The  ADC  of  the  soft  tissue  component  varies
nd  is  the  same  (55%),  less  (36%),  or  greater  (9%)  than  that
f  the  normal  cerebral  parenchyma  [75].  They  generally
nhance  intensely  with  contrast.  Meningeal  metastases  may
ccur  and  spinal  investigations  are  therefore  required.  They
ave  a  very  good  prognosis  because  of  their  excellent  radio-
nd  chemo-sensitivity.  Treatment  includes  chemotherapy,
hich  is  very  effective,  followed  by  radiotherapy  for  any
esidual  tumor.
Suprasellar  germinoma  (Fig.  12)  presents  with  diabetes
nsipidus,  and  visual  and  pubertal  disturbances.  The  tumor
s  only  found  3  to  6  months  after  the  onset  of  diabetes
nsipidus,  when  MR  is  normal  or  shows  only  slight  thickening
f  the  pituitary  stalk.  Hemorrhage  and  necrosis  in  the  tumor
ccur  more  often  than  with  the  pineal  tumors,  and  no  calciﬁ-
ations  are  present  [73].  The  low  ADC  and  iso-/hypointense
2-weighted  appearances  of  the  lesion  distinguish  it  from
ther  suprasellar  tumors.
The  tumor  is  located  more  often  in  the  deep  gray
uclei  in  the  Asian  population  [2,76].  It  develops  in  the
audate  and  lenticulate  nuclei  and  thalami,  although  this
ccasionally  reﬂects  thalamic  extension  of  a  pineal  tumor
hrough  the  walls  of  the  third  ventricle  [43].  It  carries
 poorer  prognosis  than  other  sites  and  is  an  initially
f
p
fytoma, which has a high ADC; c: sagittal T1-weighted image after
enhanced CT: the lesion is hyperdense on the unenhanced image
nﬁltrating  tumor,  the  larger  ones  of  which  are  more  cir-
umscribed.
on-germinomatous germ cell tumors
hese  are  the  teratomas  (10%),  choriocarcinomas,  endoder-
al  sinus  tumors  and  embryonic  carcinomas  or  mixed  tumors
2].
eratomas
eratomas  are  seen  in  children  under  10  years  old.  This  is
lso  the  most  common  neonatal  tumor  (over  50%)  and  is
ocated  in  the  pineal  region,  although  may  also  be  seen  in
he  hypothalamic  or  suprasellar  regions,  or  in  the  cerebral
emispheres  [77].  They  range  from  grade  0  tumors  (mature
issue)  to  grade  3  (immature  tissue).  The  mature  forms  con-
ain  fat,  cysts,  calciﬁcations  and  soft  tissue  components.
hey  enhance  heterogeneously  with  contrast,  particularly
n  the  tissular  parts  of  the  tumor.  The  ADC  is  increased  and
ipids  are  seen  on  MRS  [78].  The  immature,  malignant  forms
f  the  tumor  have  less  clearly  demarcated  edges  and  edema
round  the  tumor,  although  are  impossible  to  distinguish
ormally  from  mature  tumors,  unless  meningeal  spread  is
resent  [5].
Germ  cell  tumors  may  secrete  -hCG  and  alpha-
etoprotein  into  blood  and  CSF,  allowing  a positive,
979
high.  It  is  important  to  recognize  cystic  tumors,  which
are  treated  locally  (for  example,  with  bleomycin).  Solid
tumors  are  rarer  and  mixed  tumors  are  common.  Surgery
is  offered  when  the  lesion  is  distant  to  the  hypothalamus
(type  0),  or  in  contact  with  the  hypothalamus  (type  1).
If  the  tumor  and  hypothalamus  are  indissociable  (type  2),
partial  resection  is  offered,  combined  with  radiotherapy,
in  children  over  5  years  old  [82].  Recurrences  are  com-
mon.
Hypothalamic hamartoma
This  is  a  malformation  consisting  of  well-differentiated
neurones  and  glial  cells,  similar  to  normal  hypothala-
mic  tissue  [24]. It  is  characterized  by  attacks  of  gelastic
seizures  or  precocious  puberty.  Two  forms  are  seen:  intra-
hypothalamic  (sessile,  invading  the  mamillary  bodies  and
the  tuber  cinereum,  epilepsy)  or  para-hypothalamic  (pedun-
culated  and  inserted  beneath  the  roof  of  the  3rd  ventricle,
associated  with  precocious  puberty)  [24].  Appearances  are
the  same  as  those  of  the  gray  matter  on  T1WI,  and  are
slightly  hyperintense  on  T2WI,  occasionally  with  cysts  but
not  enhancing  with  contrast.
Choroid plexus tumors
Choroid  plexus  papilloma  is  a  benign  tumor  which  develops
from  the  choroid  plexuses  and  is  seen  in  the  ﬁrst  two  years  of
life.  It  is  located  in  the  lateral  ventricles  (trigone)  in  80%  of
cases  (Fig.  13),  in  the  4th  ventricle  in  16%  of  cases  and  in  the
3rd  ventricle  in  4%  of  cases  [5].  Sites  close  to  the  foramen  of
Monro  are  only  seen  in  4%  of  cases  [83]. CSF  production  by
Figure 13. Choroid plexus papilloma in a 6-year-old child. AxialCerebral  tumors:  Speciﬁc  features  in  children  
unequivocal  diagnosis  to  be  made,  which  occasionally  avoids
surgery  in  order  to  obtain  histology  [74].
Pineal tumors
These  account  for  3  to  11%  of  supratentorial  childhood
tumors  [2].  Germ  cell  (50—80%)  (cf.  section  ‘‘Germ  cell
tumors’’),  pineal  parenchymal  (15%)  and  neuroepithelial
tumors  are  seen  [79].  They  present  with  headaches  and
hydrocephalus.
Pineoblastoma
Pineoblastoma  accounts  for  40%  of  pineal  parenchymal
tumors.  This  is  a  grade  4  tumor  often  associated  with
meningeal  metastases  and  may  coexist  with  retinoblastoma.
The  appearances  of  these  lesions  on  imaging  are  similar
to  the  PNET  [2],  with  a  very  low  ADC,  distinguishing  them
from  a  germinoma,  which  has  a  comparatively  higher  ADC
[73].
Papillary pineal gland tumor
Papillary  pineal  gland  tumor  is  difﬁcult  to  distinguish  from
a  pineoblastoma,  although  it  is  reported  to  have  a  higher
signal  intensity  on  T2WI  [74].
Suprasellar tumors
These  account  for  40%  of  all  intracranial  tumors  and  gener-
ally  present  with  visual  and  endocrine  disturbances.  They
include  craniopharyngiomas,  optic  tract  gliomas  (cf.  sec-
tion  ‘‘Pilocytic  astrocytoma’’)  and  germinomas  (cf.  section
‘‘Germ  cell  tumors’’).  All  of  these  tumors  may  have  mixed
solid  and  cystic  appearances  on  imaging.  The  ADC  and  MRS
may  help  to  distinguish  them.
Craniopharyngioma
This  is  a  grade  1  tumor  seen  around  the  age  of  4/5  years
old  in  children  and  accounts  for  5  to  10%  of  childhood
brain  tumors  and  50%  of  suprasellar  masses  [35,80]. It
presents  with  visual  disturbance,  headaches  and  endocrine
abnormalities  (growth  and  weight  retardation)  and  develops
from  residues  of  the  Rathke’s  pouch  or  craniopharyn-
geal  canal  [81].  It  is  found  particularly  in  the  suprasellar
region  and  is  less  commonly  intrasellar  in  the  region  of
the  hypothalamus  and  optic  chiasma,  and  may  extend  to
the  anterior  and  middle  cerebral  fossae.  The  most  typical
tumor  in  children  is  the  adamantinomatous  form,  whereas
in  adults  the  squamous  papillary  form  is  more  common.
The  most  typical  appearances  are  those  of  a  calciﬁed,
suprasellar  cyst.  Appearances  are  hypointense  or  hyper-
intense  on  T1-weighted  and  hypointense  in  T2-weighted
imaging  (lipids,  proteins  or  blood)  and  hyperintense  on  FLAIR
imaging,  the  wall  enhancing  with  contrast.  A  tissue  com-
ponent  may  be  present,  which  enhances  heterogeneously.
The  tumor  may  surround  the  adjacent  blood  vessels.  On
MRS,  lipids  and  lactate  are  found  inside  the  cyst,  distin-
guishing  it  from  an  optic  tract  astrocytoma.  The  ADC  is
T1-weighted image after gadolinium: lobulated lesion at the trigone
of the left ventricle, enhancing with gadolinium, and containing
multiple vascular structures. Hydrocephalus is present due to the
overproduction of CSF by the tumor.
9 M.  Koob,  N.  Girard
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Figure 14. DP-T2SE axial image.
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he  tumor  explains  the  hydrocephalus  which  occurs.  Choroid
lexus  papillomas,  which  are  benign  grade  1  tumors,  are
ve  times  more  common  that  the  atypical  grade  2  papillo-
as  and  grade  3  carcinomas  [84].  The  papilloma  appears  as
 multilobular  iso-/hyperdense  mass  on  CT.  It  is  isointense
n  T1-weighted  and  iso-/hypointense  on  T2-weighted  MR,
ccasionally  with  a  more  heterogeneous  appearance  due  to
he  presence  of  necrotic  or  hemorrhagic  cystic  areas  [5].
t  enhances  intensely  with  gadolinium.  Ectatic  vessels  are
een  inside  the  tumor.  The  ADC  is  slightly  reduced  and  the
CBV  is  high,  occasionally  with  blood-brain  barrier  disrup-
ion  [45].  Carcinomas  invade  the  neighboring  parenchyma
nd  are  associated  with  peritumoral  edema,  which  may,
owever,  also  be  present  in  a  benign  papilloma  [85].
onclusion
here  is  a  very  wide  histological  range  of  childhood  brain
umors,  although  the  most  common  are  medulloblastomas,
strocytomas  and  ependymomas.  Analysis  of  the  site  of  the
esion  and  its  CT  and  MR  appearances  can  provide  a  pre-
perative  diagnosis  of  the  type  and  grade  in  the  majority  of
ases.  The  histological  classiﬁcation  of  tumors  has  been  con-
tantly  evolving  since  it  was  created.  Future  classiﬁcations
ill  incorporate  genetic  and  molecular  ﬁndings,  distinguish-
ng  subtypes  associated  with  different  prognoses,  with  more
argeted  individualized  treatments.  Imaging,  particularly
sing  advanced  techniques,  will  have  an  important  role  to
lay  to  try  and  identify  new  biomarkers,  which  correlate
ith  these  biological  subtypes.
TAKE-HOME  MESSAGES
• Childhood  brain  tumors  are  primary  intra-axial
tumors,  which  are  equally  common  in  the  posterior
fossa  and  supratentorial  regions.
• Histological  ﬁndings  are  extremely  varied  but  80%  are
accounted  for  by  gliomas  (pilocytic  astrocytoma+++),
medulloblastoma  and  ependymoma.
• Diagnosis  is  based  on  the  child’s  age,  site  of  the
tumor  and  its  CT  and  MR  appearances.
• Imaging:  an  urgent  cerebral  CT  is  performed  if  signs
of  raised  intracranial  pressure  are  present  in  order
to  plan  surgery  (with  and  without  enhancement,
diagnosis  of  a  mass,  calciﬁcation,  hemorrhage  and
density).
• Imaging:  cerebral  MR  is  part  of  the  preoperative
assessment  and  should  include  the  spinal  canal  in
posterior  fossa  tumors,  or  those  close  to  the  midline,
looking  for  meningeal  spread.
• Cerebral  MR  should  include  T1,  T2,  T2*,  diffusion-
weighted,  FLAIR,  T13D  gadolinium  (or  2  planes),  and,
if  possible,  MR  spectroscopy  and  perfusion  MR.linical case
 4-year-old  child  presented  with  left  VI  nerve  palsy.  The
hild’s  cerebral  MR  images  are  shown  on  Figs.  14—16.
A
1igure 15. Axial image, ADC mapping.
uestions
.  What  diagnosis  would  you  consider  for  the  4th  ventricle
tumor?
.  What  are  the  distinctive  features  of  each  of  these  diag-
noses?
.  Which  tumors  carry  risks  of  meningeal  spread?
.  What  is  the  speciﬁc  feature  of  the  tumor  in  this  child  and
what  is  your  diagnosis?
.  What  are  its  MR  spectroscopy  and  perfusion  MR  appear-
ances?nswers
.  Medulloblastoma,  pilocytic  astrocytoma,  ependymoma.
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[Figure 16. Axial T1-weighted image after gadolinium injection.
2.  Medulloblastoma:  a  solid  hyperdense  tumor  on  CT,  iso-
/hypointense  on  T2WI,  with  a  very  low  ADC,  reﬂecting
its  hypercellular  nature  and,  therefore,  high  grade.  Pilo-
cytic  astrocytoma:  a  solid  cystic  mass  with  enhancement
of  its  tissular  component.  The  tissue  area  appears  hypo-
dense  on  CT  and  hyperintense  on  T2WI  with  a  high  ADC,
reﬂecting  its  hypocellularity  and,  therefore,  low  grade.
Ependymoma:  a  tumor  with  characteristic  extension  into
the  foramina  of  Magendie  and  Luschka,  sheathing  the
vessels  and  nerves.
3.  Ependymoma  and  medulloblastoma.
4.  This  tumor  is  located  within  the  posterior  wall  of  the
pons.  It  is  hyperintense  on  FLAIR  imaging,  enhances  with
gadolinium  and  has  a  raised  ADC.  This  is  an  exophytic
pilocytic  astrocytoma  of  the  brain  stem  in  the  fourth
ventricle.
5.  The  perfusion  MR  of  the  pilocytic  astrocytoma  shows  a
low  rCBV  and  the  perfusion  curve  goes  over  the  baseline
reﬂecting  blood-brain  barrier  disruption.  On  MR  spec-
troscopy,  choline  is  increased  with  reduced  NAA  and
lactate  present,  simulating  a  malignant  tumor.
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